Market Cap 1.83B
Revenue (ttm) 10.27B
Net Income (ttm) 157.00M
EPS (ttm) N/A
PE Ratio 1.22
Forward PE 1.18
Profit Margin 1.53%
Debt to Equity Ratio -19.19
Volume 3,279,400
Avg Vol 2,368,216
Day's Range N/A - N/A
Shares Out 374.02M
Stochastic %K 22%
Beta 0.42
Analysts Hold
Price Target $7.00

Company Profile

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. T...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 514 744 6792
Address:
2150 St. Elzéar Blvd. West, Laval, Canada
Coolhat1
Coolhat1 Jul. 4 at 1:11 AM
$BHC good thing market it’s closed we’re safe can’t go lower next two days
0 · Reply
btradingwarehouse
btradingwarehouse Jul. 3 at 2:57 PM
$BHC ...2BULLS... ... Happy 250 years of making this Country of mine the best Country I know America Mother Far away to be perfect far ahead from others God bless America (I am not religious) ... Now about our Shit-Piece @BHC This will be another attempt to (let's make it the very last one) present my take (can't be clearer than this) Mr. P just added 12,677 shares (Restricted Share Units) at $4.93/share Mr. P holdings are ~: 430,242 shares as RSU 36,034,751 shares (OMB) With this Mr. P is now trying to lift price of BHC to the level that is exactly where he wants to be: NOT TO CHEAP TO UNDERVALUE HOLDINGS NOT TO EXPENSIVE TO ATTRACT OTHER BIG ENTITIES Translated : with such a miniscule purchase (as RSU) Mr. P is controlling huge holdings Can't be more perfect than that !!! That's why B Trading Warehouse will never trade any stock; futures only Wish you all Happy of July 4th Stay smart safe smile Life is perfect Peace Love Money
1 · Reply
kbingo12
kbingo12 Jul. 3 at 10:57 AM
$BHC 6/30/2026 Leung buys 6845, Paulson 12,677 & Wechsler 1,394 shares all at $4.93...NOT alot but not nothing.
1 · Reply
algomezus
algomezus Jul. 2 at 7:03 PM
$BHC fucking pig
0 · Reply
DMONEY1337
DMONEY1337 Jul. 2 at 6:44 PM
$BHC Any update on the Larsucosterol trial?
1 · Reply
Coolhat1
Coolhat1 Jul. 2 at 3:15 PM
$BHC $BLCO going up
0 · Reply
Trigga_tha_Gambler
Trigga_tha_Gambler Jul. 1 at 4:16 PM
$BHC Lol. Losses pilling up.
1 · Reply
Trigga_tha_Gambler
Trigga_tha_Gambler Jul. 1 at 3:44 PM
$BHC Lol. Traders selling at interday lows at a loss. Lol. Makes sense.
1 · Reply
FibonacciTrader_
FibonacciTrader_ Jun. 30 at 1:51 PM
Notable options flow printing across a mix of turnaround, industrial, and speculative beta names. $BB - 15C 8/21 exp, $600K flow, 1.17 avg $CGNX - 75C 7/17 exp, $500K flow, ~1 avg $METC - 13C 7/17 exp, $1.2M flow, 0.85 avg $BHC -6C 8/21 exp, $181K flow, 0.16 avg $FLY - 35C 8/21 exp, $500K flow, 2.7 avg What stands out here is the risk appetite clustering in lower-priced and cyclical names-this isn’t defensive flow, it’s directional speculation into upside continuation and potential re-rating stories. Next alert is coming soon. If you’re not following with notifications on, you’re likely seeing the move after it already happened.
0 · Reply
Coolhat1
Coolhat1 Jun. 29 at 11:05 PM
$BHC who else has been here before the split and still in it. How disappointing has it been
1 · Reply
Latest News on BHC
Bausch Health Companies Transcript: AGM 2026

May 19, 2026, 9:00 AM EDT - 6 weeks ago

Bausch Health Companies Transcript: AGM 2026


Bausch Health Companies Earnings Call Transcript: Q1 2026

Apr 29, 2026, 5:00 PM EDT - 2 months ago

Bausch Health Companies Earnings Call Transcript: Q1 2026


Bausch Health Companies Slides: Q1 2026

Apr 29, 2026, 5:00 PM EDT - 2 months ago

Bausch Health Companies Slides: Q1 2026


Bausch Health Companies Earnings release: Q1 2026

Apr 29, 2026, 5:00 PM EDT - 2 months ago

Bausch Health Companies Earnings release: Q1 2026


Bausch Health Companies Quarterly report: Q1 2026

Apr 29, 2026, 5:00 PM EDT - 2 months ago

Bausch Health Companies Quarterly report: Q1 2026


Bausch Health reports Q1 non-GAAP EPS 78c, consensus 69c

2026-04-29T20:33:36.000Z - 2 months ago

Bausch Health reports Q1 non-GAAP EPS 78c, consensus 69c


BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTS

Apr 29, 2026, 4:05 PM EDT - 2 months ago

BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTS


Bausch Health Companies Proxy statement: Proxy filing

Apr 8, 2026, 8:00 AM EDT - 3 months ago

Bausch Health Companies Proxy statement: Proxy filing


Bausch Health Companies Proxy statement: Proxy filing

Apr 8, 2026, 8:00 AM EDT - 3 months ago

Bausch Health Companies Proxy statement: Proxy filing


Bausch Health price target lowered to $7 from $8 at Barclays

2026-02-25T10:15:55.000Z - 4 months ago

Bausch Health price target lowered to $7 from $8 at Barclays


Bausch Health Companies Earnings Call Transcript: Q4 2025

Feb 18, 2026, 5:00 PM EST - 4 months ago

Bausch Health Companies Earnings Call Transcript: Q4 2025


Bausch Health Companies Annual report: Q4 2025

Feb 18, 2026, 5:00 PM EST - 4 months ago

Bausch Health Companies Annual report: Q4 2025


Bausch Health Companies Earnings release: Q4 2025

Feb 18, 2026, 5:00 PM EST - 4 months ago

Bausch Health Companies Earnings release: Q4 2025


Bausch Health Companies Slides: Q4 2025

Feb 18, 2026, 5:00 PM EST - 4 months ago

Bausch Health Companies Slides: Q4 2025


Bausch Health reports Q4 EPS (30c) vs. 25c a year ago

2026-02-18T21:21:45.000Z - 4 months ago

Bausch Health reports Q4 EPS (30c) vs. 25c a year ago


NY AG announces settlement with Lannett and Bausch Health

2026-02-02T19:40:25.000Z - 5 months ago

NY AG announces settlement with Lannett and Bausch Health


Bausch Health Provides Update on RED-C Phase 3 Clinical Trials

Jan 23, 2026, 7:45 AM EST - 5 months ago

Bausch Health Provides Update on RED-C Phase 3 Clinical Trials


Bausch Health price target raised to $8 from $7 at Truist

2026-01-07T12:20:14.000Z - 6 months ago

Bausch Health price target raised to $8 from $7 at Truist


Bausch Health initiated with an Equal Weight at Barclays

2025-12-08T21:31:57.000Z - 7 months ago

Bausch Health initiated with an Equal Weight at Barclays


Bausch Health rises 14.8%

2025-12-01T17:00:16.000Z - 7 months ago

Bausch Health rises 14.8%


Bausch Health rises 11.3%

2025-12-01T15:05:36.000Z - 7 months ago

Bausch Health rises 11.3%


Bausch Health launches offers to exchange senior secured notes

2025-11-24T12:50:20.000Z - 7 months ago

Bausch Health launches offers to exchange senior secured notes


Bausch + Lomb to Hold Investor Day on Nov. 13

Nov 3, 2025, 4:30 PM EST - 8 months ago

Bausch + Lomb to Hold Investor Day on Nov. 13


Bausch Health Companies Earnings Call Transcript: Q3 2025

Oct 29, 2025, 5:00 PM EDT - 8 months ago

Bausch Health Companies Earnings Call Transcript: Q3 2025


Bausch Health Companies Quarterly report: Q3 2025

Oct 29, 2025, 5:00 PM EDT - 8 months ago

Bausch Health Companies Quarterly report: Q3 2025


Bausch Health Companies Earnings release: Q3 2025

Oct 29, 2025, 5:00 PM EDT - 8 months ago

Bausch Health Companies Earnings release: Q3 2025


Bausch Health Companies Slides: Q3 2025

Oct 29, 2025, 5:00 PM EDT - 8 months ago

Bausch Health Companies Slides: Q3 2025


Bausch Health Announces Third Quarter 2025 Results

Oct 29, 2025, 4:05 PM EDT - 8 months ago

Bausch Health Announces Third Quarter 2025 Results


Bausch Health Companies Proxy statement: Proxy Filing

Aug 27, 2025, 8:00 AM EDT - 11 months ago

Bausch Health Companies Proxy statement: Proxy Filing


Bausch + Lomb board members resign after Icahn agreement ends

Aug 18, 2025, 5:48 PM EDT - 11 months ago

Bausch + Lomb board members resign after Icahn agreement ends


Bausch Health Companies Proxy statement: Proxy Filing

Aug 13, 2025, 8:00 AM EDT - 11 months ago

Bausch Health Companies Proxy statement: Proxy Filing


Bausch Health Companies Earnings Call Transcript: Q2 2025

Jul 30, 2025, 5:00 PM EDT - 1 year ago

Bausch Health Companies Earnings Call Transcript: Q2 2025


Bausch Health Companies Quarterly report: Q2 2025

Jul 30, 2025, 5:00 PM EDT - 1 year ago

Bausch Health Companies Quarterly report: Q2 2025


Bausch Health Companies Earnings release: Q2 2025

Jul 30, 2025, 5:00 PM EDT - 1 year ago

Bausch Health Companies Earnings release: Q2 2025


Bausch Health Companies Slides: Q2 2025

Jul 30, 2025, 5:00 PM EDT - 1 year ago

Bausch Health Companies Slides: Q2 2025


Bausch Health Announces Second Quarter 2025 Results

Jul 30, 2025, 4:05 PM EDT - 1 year ago

Bausch Health Announces Second Quarter 2025 Results


Coolhat1
Coolhat1 Jul. 4 at 1:11 AM
$BHC good thing market it’s closed we’re safe can’t go lower next two days
0 · Reply
btradingwarehouse
btradingwarehouse Jul. 3 at 2:57 PM
$BHC ...2BULLS... ... Happy 250 years of making this Country of mine the best Country I know America Mother Far away to be perfect far ahead from others God bless America (I am not religious) ... Now about our Shit-Piece @BHC This will be another attempt to (let's make it the very last one) present my take (can't be clearer than this) Mr. P just added 12,677 shares (Restricted Share Units) at $4.93/share Mr. P holdings are ~: 430,242 shares as RSU 36,034,751 shares (OMB) With this Mr. P is now trying to lift price of BHC to the level that is exactly where he wants to be: NOT TO CHEAP TO UNDERVALUE HOLDINGS NOT TO EXPENSIVE TO ATTRACT OTHER BIG ENTITIES Translated : with such a miniscule purchase (as RSU) Mr. P is controlling huge holdings Can't be more perfect than that !!! That's why B Trading Warehouse will never trade any stock; futures only Wish you all Happy of July 4th Stay smart safe smile Life is perfect Peace Love Money
1 · Reply
kbingo12
kbingo12 Jul. 3 at 10:57 AM
$BHC 6/30/2026 Leung buys 6845, Paulson 12,677 & Wechsler 1,394 shares all at $4.93...NOT alot but not nothing.
1 · Reply
algomezus
algomezus Jul. 2 at 7:03 PM
$BHC fucking pig
0 · Reply
DMONEY1337
DMONEY1337 Jul. 2 at 6:44 PM
$BHC Any update on the Larsucosterol trial?
1 · Reply
Coolhat1
Coolhat1 Jul. 2 at 3:15 PM
$BHC $BLCO going up
0 · Reply
Trigga_tha_Gambler
Trigga_tha_Gambler Jul. 1 at 4:16 PM
$BHC Lol. Losses pilling up.
1 · Reply
Trigga_tha_Gambler
Trigga_tha_Gambler Jul. 1 at 3:44 PM
$BHC Lol. Traders selling at interday lows at a loss. Lol. Makes sense.
1 · Reply
FibonacciTrader_
FibonacciTrader_ Jun. 30 at 1:51 PM
Notable options flow printing across a mix of turnaround, industrial, and speculative beta names. $BB - 15C 8/21 exp, $600K flow, 1.17 avg $CGNX - 75C 7/17 exp, $500K flow, ~1 avg $METC - 13C 7/17 exp, $1.2M flow, 0.85 avg $BHC -6C 8/21 exp, $181K flow, 0.16 avg $FLY - 35C 8/21 exp, $500K flow, 2.7 avg What stands out here is the risk appetite clustering in lower-priced and cyclical names-this isn’t defensive flow, it’s directional speculation into upside continuation and potential re-rating stories. Next alert is coming soon. If you’re not following with notifications on, you’re likely seeing the move after it already happened.
0 · Reply
Coolhat1
Coolhat1 Jun. 29 at 11:05 PM
$BHC who else has been here before the split and still in it. How disappointing has it been
1 · Reply
Coolhat1
Coolhat1 Jun. 29 at 8:47 PM
$BHC if anyone has a brain at $COO they would merge with $BLCO and hire Brent as ceo to take over and have him sell it for a large premium. Look at what he did with forest lab allergen and actavis. Merged all of them
1 · Reply
Coolhat1
Coolhat1 Jun. 29 at 7:28 PM
$BHC the chairman is Paulson with a large stake in the company and Thomas appio is the ceo he has been working here a long time over 16 years with the company and has a lot of equity in it. They gave A lot of incentive to make this work. Brent sold blco before and sold many larger company’s at premium. I think in the end this would most likely work out
0 · Reply
AKTN
AKTN Jun. 29 at 2:32 PM
$BHC didn't this drop 40% when Norwich news first hit? Now Norwich is out of the picture for a few years, nothing but red.
0 · Reply
gary918
gary918 Jun. 29 at 11:26 AM
$BHC Icahn was pushing for a special dividend on the equity to move the price so he could move on. Paulson thought Red-C would meet end points and opposed the dividend so he bought the Icahn block. If Icahn dumped 27 million shares on the market it would have been a big price drop. We know what happened. Which brings us to Thursday and Friday. Appio had said a ruling would come out after April. Those who knew the court calendar started buying moving the shares close to $6. My guess is, someone was using this last catalyst as an opportunity to liquidate some shares. As an aside, when Norwich first filed I spoke to a top patent attorney who said there was minimal chance they would win. But if we remember, the stock sunk almost 50%. It never recovered as the Company was never able to convince Wall Street of the lack of merit. Now we wait to see if there are at least some dip buyers
0 · Reply
kbingo12
kbingo12 Jun. 27 at 8:21 PM
$BHC This ruling acts as a major defense shield for Bausch Health’s Xifaxan. The Timeline: Because the Supreme Court already refused to review the patent side of this case late last year, and this separate FDA-focused appeal has now been shot down, Bausch Health has successfully locked down its Xifaxan market exclusivity against Norwich until October 2029. (Note: Bausch has separate settlements allowing other manufacturers like Teva, Sun, and Sandoz to enter the market slightly earlier in 2028, but Norwich remains blocked.)
0 · Reply
kbingo12
kbingo12 Jun. 27 at 8:19 PM
$BHC Yesterday, on June 26, 2026, the U.S. Court of Appeals for the D.C. Circuit handed Norwich Pharmaceuticals Inc. another major loss in its ongoing battle to launch a generic version of Bausch Health’s blockbuster drug, Xifaxan® (rifaximin) 550 mg. The appellate court affirmed a lower court's summary judgment in favor of the FDA and Bausch’s subsidiary, Salix Pharmaceuticals, effectively keeping Norwich's generic off the market until October 2029.
0 · Reply
ThinkItThrough
ThinkItThrough Jun. 27 at 2:30 PM
$BHC this thing should rip on Monday given the final decision… which means it probably won’t given its track record!
5 · Reply
Rpate
Rpate Jun. 27 at 3:57 AM
$BHC Norwich lost against FDA https://law.justia.com/cases/federal/appellate-courts/cadc/23-5311/23-5311-2026-06-26.html
1 · Reply
Coolhat1
Coolhat1 Jun. 26 at 9:23 PM
$BHC just agony and pain is all shareholders get
0 · Reply
Coolhat1
Coolhat1 Jun. 26 at 9:21 PM
$BHC ever stock is up 300% and this has been making me lose money for 6 years straight it’s omg I just can’t
0 · Reply
Trigga_tha_Gambler
Trigga_tha_Gambler Jun. 26 at 8:03 PM
$BHC Lol. Scared traders taking it on the chin today!
0 · Reply
Bullchart
Bullchart Jun. 26 at 7:57 PM
$BHC Massive stops got hit today. Wow
0 · Reply